Skip to main content

Established system-wide biobanking

Beginning in 2007, Geisinger began a biobanking initiative at the direction of the external Scientific Advisory Board in recognition of the role genomics would play in the future of medicine and Geisinger's focus on individualized medicine and care.

In 2013 MyCode® was expanded to the MyCode® Community Health Initiative to include exome and genome sequencing and a commitment to the return of clinically actionable research results. Sample collection occurs in primary care, specialty and pediatric clinics. Consenting and collection of samples during community events began in 2014.

Standardized specimen container type, transport, location tracking and storage for 3,000+ patient encounters per day provide quality serum, RNA and DNA specimens. An Institutional Review Board-approved system is in place to allow the retrieval and storage of clinical specimens from consented participants that are scheduled to be destroyed. Clinical Laboratory Improvement Amendments-approved (CLIA) samples are available for research, and the MyCode biobank is CLIA-certified. All samples are linked by a unique code to the Geisinger Epic electronic medical record.

For more information about the MyCode® Community Health Initiative and biobanking activities at Geisinger, contact Carroll Flansburg, at or 855-636-0019.